Plasma dopamine: regulation and significance.
Dopamine (DA) normally circulates in plasma. The plasma concentration of the free form of DA is approximately equivalent to that of epinephrine (E) and 20% that of norepinephrine (NE). The free form constitutes less than 2% of total plasma DA, and the remainder exists predominantly as sulfate or glucuronide conjugates. DA is found in adrenal medulla and cortex, peripheral nerves, sympathetic ganglia, carotid body, and kidney, but quantitatively the origin of circulating DA remains poorly understood. Plasma concentrations of free DA increase in association with events that increase sympathetic tone, although to a much lesser degree than seen for NE or E. Thus, upright posture, bicycle exercise, a variety of emotional and physical stresses, and hypoglycemia may be associated with increases in plasma free DA. Plasma DA decreases during the course of dietary sodium depletion in humans, in contrast to the plasma NE response, and consistent with a physiological role for DA in the regulation of aldosterone secretion. Plasma DA increases after administration of its precursor L-dihydroxyphenylalanine, together with the decarboxylase inhibitor carbidopa. Plasma NE and (in some studies) plasma DA decrease after administration of the DA receptor agonist bromocriptine. In contrast, plasma DA and one of its major metabolites, homovanillic acid, increase after administration of the DA receptor antagonist haloperidol. Administration of the endogenous opioid peptide beta-endorphin into the brain increases central sympathetic outflow, thus increasing plasma DA concentration, although to a lesser extent than for NE or E. Disordered basal concentrations of DA in plasma or disordered responses of plasma DA have been reported in a number of disease states. Clear understanding of physiological roles of DA in plasma and of its pathophysiology awaits definition.
D000172:Acromegaly / Q000097:blood; D000758:Anesthesia; D000818:Animals; D001921:Brain / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000097:blood; D004285:Dogs; D004298:Dopamine / Q000097:blood*; D004723:Endorphins / Q000378:metabolism; D005260:Female; D005609:Free Radicals; D006801:Humans; D008297:Male; D011187:Posture; D011388:Prolactin / Q000097:blood; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D012727:Sex Characteristics; D013312:Stress, Physiological / Q000097:blood; D013564:Sympathetic Nervous System / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution
D004723:Endorphins; D005609:Free Radicals; D011954:Receptors, Dopamine; D004295:Dihydroxyphenylalanine; D011388:Prolactin; D004298:Dopamine